J Korean Diabetes Assoc.
2004 Apr;28(2):51-62.
Therapeutic Potential of the Glucagon-like Peptide-1
- Affiliations
-
- 1Department of Internal Medicine, College of Medicine, Inje University, Korea.
- 2Department of Internal Medicine, College of Medicine, Kyung Hee University, Korea.
- 3Department of Internal Medicine, College of Medicine, Hanyang University, Korea.
Abstract
- No abstract available.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Glucagon-like Peptide-1 Analogue and Dipeptidyl Peptidase-IV Inhibitors
- Letter: Expression of Glucagon-Like Peptide-1 Receptor in Papillary Thyroid Carcinoma and Its Clinicopathologic Significance (Endocrinol Metab 2014;29:536-44, Min Jung Jung et al.)
- New Potential Targets of Glucagon-Like Peptide 1 Receptor Agonists in Pancreatic β-Cells and Hepatocytes
- Gut Hormones and Appetite Control: A Focus on PYY and GLP-1 as Therapeutic Targets in Obesity
- New Treatment for Type 2 Oiabetes: GLP-1 Analogue
